Jianmei Wu Leavenworth

10PUBLICATIONS
23CO-AUTHORS
Molecular targetsOptometryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 30, 2025
Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma.

Jeffrey M Grimes, Sadashib Ghosh, Shamza Manzoor

|Aug 09, 2023
Two different isoforms of osteopontin modulate myelination and axonal integrity.

Gisela Nilsson, Amin Mottahedin, Aura Zelco

|Sep 30, 2022
Analysis of the In Vivo Function of Follicular Regulatory T (TFR) Cells in the Regulation of Antibody Response.

Lin Luo, Jianmei W Leavenworth

|Feb 05, 2022
RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity.

Zhuo Zhang, Lin Luo, Chuan Xing

|Feb 02, 2022
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.

Katherine E Miller, Kevin A Cassady, Justin C Roth

|Nov 20, 2021
Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade.

Michael L Dixon, Lin Luo, Sadashib Ghosh

Pageof 2

Frequent Collaborators

2 joint publications

James M Markert

2 joint publications

Sadashib Ghosh

1 joint publications

Kathleen M Schieffer

1 joint publications

Kristen Leraas